Search results
In discussing prostate cancer prevention, it is important to consider differential risks for incident, recurrent, and progressive prostate cancer and to stratify men appro-priately.
1 gru 2010 · We recommend consideration of 5-ARIs for prostate cancer prevention in (1) asymptomatic men with a PSA ≤ 3.0 ng ml (-1) who are undergoing or anticipate undergoing PSA screening for early...
25 cze 2020 · Download PDF. Highlights. •. This ESMO Clinical Practice Guideline provides key recommendations on the management of prostate cancer. •. Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe. •. Key treatment recommendations are provided. •.
7 mar 2024 · Prostate cancer prevention strategies include avoiding risk factors, increasing protective factors, and considering chemoprevention when appropriate. Get detailed information about factors that influence the risk of prostate cancer and research aimed at preventing it in this clinician summary.
7 lis 2020 · Updated prostate cancer guidelines are presented, addressing screening, diagnosis, and local treatment with curative intent. These guidelines rely on the available scientific evidence, and new insights will need to be considered and included on a regular basis.
Prostate cancer is the leading cause of non-skin cancer in the US, and the second leading cause of cancer worldwide; approximately 1 in 8 men will be diagnosed with prostate cancer at some point in their lives. The older you are, the more likely you are to be diagnosed with prostate cancer. Although only about 1 in 350 men under age 50 will
Prevention is an important strategy for limiting prostate cancer morbidity and mortality. Two major types of prevention are primary (reduction of incident cases) and tertiary (inhibition of disease progression and recurrence).
